Showing results (101-110 of 138) with videos related to
Sort By:
Pageof 14
Stem Cell Reports|December 4, 2018
The MicroRNA-371 Family as Plasma Biomarkers for Monitoring Undifferentiated and Potentially Malignant Human Pluripotent Stem Cells in Teratoma AssaysDaniela C F Salvatori, Lambert C J Dorssers, Ad J M Gillis, et al.Transplantation|November 17, 2018
Cell-free MicroRNA miR-505-3p in Graft Preservation Fluid Is an Independent Predictor of Delayed Graft Function After Kidney TransplantationHenk P Roest, Liselotte S S Ooms, Ad J M Gillis, et al.Genes, Chromosomes & Cancer|July 11, 2007
Gene expression profiling and gene copy-number changes in malignant mesothelioma cell linesClaudia Zanazzi, Remko Hersmus, Imke M Veltman, et al.British Journal of Cancer|February 12, 2019
Molecular heterogeneity and early metastatic clone selection in testicular germ cell cancer developmentLambert C J Dorssers, Ad J M Gillis, Hans Stoop, et al.Plos One|June 3, 2014
Seminoma and embryonal carcinoma footprints identified by analysis of integrated genome-wide epigenetic and expression profiles of germ cell cancer cell linesYvonne G van der Zwan, Martin A Rijlaarsdam, Fernando J Rossello, et al.British Journal of Cancer|August 18, 2011
Specific detection of OCT3/4 isoform A/B/B1 expression in solid (germ cell) tumours and cell lines: confirmation of OCT3/4 specificity for germ cell tumoursM A Rijlaarsdam, H A D M van Herk, A J M Gillis, et al.The Journal of Pathology|September 26, 2007
High-throughput microRNAome analysis in human germ cell tumoursA J M Gillis, H J Stoop, R Hersmus, et al.European Urology Open Science|November 5, 2021
Paclitaxel, Ifosfamide, and Cisplatin in Patients with Poor-prognosis Disseminated Nonseminomatous Germ Cell Tumors with Unfavorable Serum Tumor Marker Decline After First Cycle of Chemotherapy. The GCT-SK-003 Phase II TrialMichal Mego, Katarina Rejlekova, Daniela Svetlovska, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2022
Chromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent Predictor of Poor Outcome in Male Malignant Germ Cell TumorsDennis M Timmerman, Thomas F Eleveld, Sruthi Sriram, et al.Cancer Cell International|August 11, 2020
Napabucasin overcomes cisplatin resistance in ovarian germ cell tumor-derived cell line by inhibiting cancer stemnessSilvia Schmidtova, Lambert C J Dorssers, Katarina Kalavska, et al.Pageof 14